WILEY

KNOWLEDGE FOR GENERATIONS

WILEY - KNOWLEDGE FOR GENERATIONS

United States Change Location

cart.gif CART |  MY ACCOUNT |  CONTACT US |  HELP    
Cover image for product 0471223808
Guiding Icarus: Merging Bioethics with Corporate Interests
ISBN: 978-0-471-22380-1
Paperback
296 pages
April 2002
US $34.95 Add to Cart

This price is valid for United States. Change location to view local pricing and availability.

  • Description
  • Table of Contents
  • Reviews
"...particularly useful to corporate biotech managers due to Dhanda's explanation of the issues and suggestions on how to engage the public...inherent value in this discourse is how Dhanda explains how an ethical biotech business is likely to be a successful one." (Genomics & Proteomics, May 2002)

"useful to biotechnologists, regulatory affairs managers, and corporate officers of biotech firms, as well as bioethicists..." (Genetic Engineering News, July 2002)

"...if you read The Economist you'll doubtless find this of interest..." (Focus, August 2002)

"...offers an insider's view on why a bridge is needed to merge bioethics with corporate needs...written for the general audience...is especially useful to biotechnologists, regulatory affairs managers, and corporate officers of biotech firms, as well as bioethicists..." (Genetic Engineering News, Vol. 22, No. 13, July 2002)

"...lays out a blueprint for executives...focusing on four subjects..." (HBS (Harvard Business School) Working Knowledge, July 2002)

"This book should stimulate much useful discussion in the biotechnology industry...the author should be congratulated." (Nature Biotechnology, August 1, 2002)

"...a must read for those interested in understanding how bioethics can help industry develop ethically and socially responsible biotechnologies." (Canadian Medical Association Journal, August 20, 2002)

"Dhanda applies a case study approach to four timely topics: genetically modified foods, DNA databanking, personalized medicine, and stem cell research. In each case, Dhanda gives a very basic review of the science, discusses the potential benefits of the technology and the ethical issues, and then uses prominent corporate examples to raise relevant issues and draw lessons." (JAMA, January 22/29, 2003-Vol 289, No. 4)

"The time couldn’t be better for a book on the ethical issues associated with biotechnology...discussions...are clearly welcome and needed." (Journal of the American Medical Association, Vol. 289, No. 4, January 2003)

"…an interesting and useful resource for any industry insider…" (Chemistry & Industry)

“…an interesting and useful resource for any industry insider…”(Chemistry & Industry, 21 April 2003)